Facebook
Twitter
LinkedIn
Google+
Forward
Survivorship and Side Effect Management in Patients With Multiple Myeloma: Part of the 2016 Advanced Clinical Educator Program in Multiple Myeloma
This activity includes:
- CE-Certified Live ACE Candidate Institutional Presentation
Purpose
The goal of this activity is to improve participants’ knowledge and competence to identify and manage the potential adverse effects associated with multiple myeloma and its treatment.
Course Overview
According to the International Myeloma Working Group (IMWG), bone disease, renal damage, hematologic toxicities, infections, thromboembolism, and peripheral neuropathy are the most frequent disabling events in patients with multiple myeloma requiring prompt and active supportive care (Palumbo et al, 2014). This activity will review disease- and treatment-related side effects, strategies for side effect management, and survivorship issues.
Advanced Clinical Educator (ACE) Candidates are providing this presentation as part of the 2016 Advanced Clinical Educator Program in Multiple Myeloma to become subject matter experts and speakers in this therapeutic area and receive ACE certification.
Target Audience
This activity is designed for oncology/hematology nurses who treat or manage multiple myeloma.
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Describe effective nursing management of common adverse events, including skeletal-related events, peripheral neuropathy, and deep venous thrombosis
- Identify how to help patients cope with long-term survivorship issues
- Develop education strategies to help patients understand how to recognize and manage side effects
Activity Agenda
- Overview of side effects of therapies
- Prophylaxis and management of skeletal-related events; effect of bisphosphonates on survival
- Nursing management of peripheral neuropathy
- Treatment strategies for deep venous thrombosis
- Interventions for infection
- Long-term survivorship issues
- Survivorship care planning: developing a plan and discussing it with your patients
- Patient education about monitoring, reporting, and managing side effects
- Interactive nurse-centric case studies
Co- Chairpersons | |
 | Beth Faiman, PhD, RN, APRN-BC, AOCN® |
 | Sandra E. Kurtin, MS, RN, ANP-C, AOCN® |
| ACE Candidate Faculty Speakers: | |
| Kelly Clark, MSN, RN, OCN® Registered Nurse Banner University Medical Center Tuscon, Arizona | |
| Carmela Cuccurullo, MSN, RN, APN, OCN® Clinical Nurse Educator John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey | |
| Pamela A. Gaytan, BSN, RN Registered Nurse Clinician Rocky Mountain Cancer Center Denver, Colorado | |
| Natalie Halladay, MS, RN, FNP-BC Nurse Practitioner, Lymphoma/Myeloma The University of Texas MD Anderson Cancer Center Houston | |
| Kashmir Horton, BSN, RN, OCN Registered Nurse Certified Specialist Banner University Medical Center Phoenix, Arizona | |
| Michelle Koch, MS, RN, APN Family Nurse Practitioner Englewood Hospital & Medical Center Englewood, New Jersey | |
| Dennis Leenig, Jr., MSN, RN, NP-C, OCN® Registered Nurse John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey | |
| Rebecca Lu, MSN, RN, FNP-C Advanced Practice Registered Nurse The University of Texas MD Anderson Cancer Center Houston | |
| Laura McPheeters, MSN, FNP Family Nurse Practitioner The University of Arizona Cancer Center Tucson, Arizona | |
| Candice Preble, BSN, RN, OCN Blood & Marrow Transplant Coordinator Banner University Medical Center Tucson, Arizona | |
| Ashley Rayner, BSN, RN Advanced Nurse Clinician Emory Johns Creek Infusion Center Johns Creek, Georgia | |
| Angelina Scala, BSN, RN, OCN Infusion Nurse Rocky Mountain Cancer Center – Midtown Denver, Colorado | |
| Todd Snyder, RN Outpatient Nurse Lymphoma/ Myeloma Clinic The University of Texas MD Anderson Cancer Center Houston, Texas | |
| Mary Steinbach, DNP, APRN Nurse Practitioner Division of Hematology and Hematologic Malignancies University of Utah Huntsman Cancer Hospital Salt Lake City | |
| Kristian Vasudev, BSN, BBA Nurse Clinician III Emory Healthcare Atlanta, Georgia | |
| Melanie Watson, ASN, RN, OCN Myeloma Team Nurse Winship Cancer Institute at Emory University Atlanta, Georgia | |
| LaKeisha T. White, BSN, BS, RN Registered Nurse (BMT) Winship Cancer Institute at Emory University Atlanta, Georgia | |
CONTINUING EDUCATION
Nursing Continuing Education
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.
This educational activity for 1.0 contact hour for each module is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com
Instructions to Receive Credit
To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Completion of the post-test with a score of 75% or better and the post-activity evaluation is requested. Your statement of credit will be emailed to you within 3 weeks.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Faculty or Presenter | Reported Financial Relationship |
Beth Faiman, PhD, RN, APRN-BC, AOCN® | Consultant/Independent contractor: Celgene Corporation; Millennium Pharmaceuticals, Inc.; Onyx Pharmaceuticals, Inc.; Speakers' bureau: Celgene Corporation; Millennium Pharmaceuticals, Inc.; Onyx Pharmaceuticals, Inc. |
Sandra E. Kurtin, MS, RN, ANP-C, AOCN® | Consultant/Independent contractor: Bristol-Myers Squibb Company; Celgene Corporation; Novartis Pharmaceuticals Corporation; Onyx Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Honoraria: Bristol-Myers Squibb Company; Celgene Corporation; Novartis Pharmaceuticals Corporation; Onyx Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited. |
| Kelly Clark, MSN, RN, OCN® | Kelly Clark, MSN, RN, OCN®, has no real or apparent conflicts of interest to report. |
| Carmela Cuccurullo, MSN, RN, APN, OCN® | |
| Pamela A. Gaytan, BSN, RN | Pamela A. Gaytan, BSN, RN, reported a financial interest/relationship or affiliation in the form of Advisor, Lexicon Pharmaceuticals, Inc.; Speakers' bureau, Ipsen Pharmaceuticals. |
| Natalie Halladay, MS, RN, FNP-BC | Natalie Halladay, MS, RN, FNP-BC, has no real or apparent conflicts of interest to report. |
| Kashmir Horton, BSN, RN, OCN | Kashmir Horton, BSN, RN, OCN®, has no real or apparent conflicts of interest to report. |
| Michelle Koch, MS, RN, APN | Michelle Koch, MS, RN, has no real or apparent conflicts of interest to report. |
| Dennis Leenig, Jr., MSN, RN, NP-C, OCN® | Dennis Leenig, Jr., MSN, RN, NP-C, OCN®, has no real or apparent conflicts of interest to report. |
| Rebecca Lu, MSN, RN, FNP-C | Rebecca Lu, MSN, RN, FNP-C, has no real or apparent conflicts of interest to report. |
| Laura McPheeters, MSN, FNP | Laura McPheeters, MSN has no real or apparent conflicts of interest to report. |
| Candice Preble, BSN, RN, OCN | Candice Preble, BSN, RN, OCN®, has no real or apparent conflicts of interest to report. |
| Ashley Rayner, BSN, RN | Ashley Rayner, BSN, RN, has no real or apparent conflicts of interest to report. |
| Todd Snyder | Todd Snyder has no real or apparent conflicts of interest to report. |
| Mary Steinbach, DNP, APRN | Mary Steinbach, DNP, APRN, reported a financial interest/relationship or affiliation in the form of Speakers' bureau, Amgen, Inc., Onyx Pharmaceuticals, Inc., Taragara Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc. |
| Kristian Vasudev, BSN, BBA | Kristian Vasudev, BSN, BBA, has no real or apparent conflicts of interest to report. |
| Melanie Watson, ASN, RN, OCN | Melanie Watson, ASN, RN, OCN®, has no real or apparent conflicts of interest to report. |
| LaKeisha T. White, BSN, BS, RN | LaKeisha T. White, BSN, BS, RN has no real or apparent conflicts of interest to report. |
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Planner or Manager | Reported Financial Relationship |
| Ashley Marostica, RN, MSN | Nothing to disclose |
| Lindsay Borvansky | Nothing to disclose |
| Andrea Funk | Nothing to disclose |
| Laura Gilsdorf | Nothing to disclose |
| Linda Gracie-King, MS | Nothing to disclose |
| Ronald Viggiani, MD | Nothing to disclose |
Isabelle Vacher | Nothing to disclose |
| Jocelyn Timko, BS | Nothing to disclose |
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and AXIS Medical Education do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Americans with Disabilities Act
In compliance with the Americans with Disabilities Act, we will make every reasonable effort to accommodate your request.
This activity is supported by educational grants provided by Celgene Corporation, Novartis Pharmaceuticals, and Takeda Oncology.
There is no fee for this educational activity.
This activity is provided by
AXIS 1390-M3
Available Credit
- 1.00 ANCC